Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

4 Stocks To Watch: CLVS, HTGM, MTCH, TWTR

Published 02/14/2018, 12:18 AM
Updated 07/09/2023, 06:31 AM

Clovis Oncology Inc (NASDAQ:CLVS) was up 1.70, or 3.2%, to 54.76, on 1.2 million shares traded on Tuesday. I believe it completed four waves down and is at support going back a year. More importantly, on a 50-minute chart, it looks like an inverse head-and-shoulders just formed, or a right-handed extended V. Tuesday’s action took it right above support, and it’s flagging. If it pops on Wednesday, it may quickly run to 58 and 63, my swing trade.

HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) gained 43 cents, or 10.6%, to 4.48, on 3.4 million shares traded on Tuesday. It exploded on Monday, going all the way up to 4.69, and then on Tuesday, it got down to 3.82, reversed and closed at the high for the day. If it gets over 4.70, you might see 5.30-.40 as early as Wednesday.

Match Group, Inc. (NASDAQ:MTCH) is stellar, jumping 1.61, or 4.24%, to 39.60, on 3.6 million shares traded on Tuesday. I’ve been watching this stock since it was given to me by one of my clients in Aug at 20, and since it has almost doubled. The all-time high has already extended, but momentum is very strong, so it may get into low 40’s short-term.

Twitter, Inc. (NYSE:TWTR) ran 2.49, or 8%, to 33.44, on 58 million shares traded on Tuesday. Last week, it had a 232-million shares day, pulled back, and not only held the gap, but held the top of the prior channel, which is very bullish. Sometimes when you see that, if you can angle the channel, it may very well be headed to a 38 target.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

On the long side, stocks included Ampio Pharmaceuticals, Inc. (NYSE:AMPE), Aqua Metals, Inc. (NASDAQ:AQMS), Atara Biotherapeutics, Inc. (NASDAQ:ATRA), Cymabay Therapeutics, Inc. (NASDAQ:CBAY), CHEGG, INC (NYSE:CHGG), Clovis Oncology Inc (NASDAQ:CLVS), Ceragon Networks Ltd. (NASDAQ:CRNT), CRISPR Therapeutics AG (NASDAQ:CRSP), eGain Corporation (NASDAQ:EGAN), 8x8, Inc. (NYSE:EGHT), Health Insurance Innovations, Inc. (NASDAQ:HIIQ), HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM), Innoviva, Inc. (NASDAQ:INVA), Mimecast Limited (NASDAQ:MIME), Match Group, Inc. (MTCH), Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), Qualys, Inc. (NASDAQ:QLYS), QuinStreet, Inc. (NASDAQ:QNST), Twitter, Inc. (TWTR), Under Armour, Inc. (NYSE:UAA), Unisys Corporation (NYSE:UIS), Veeco Instruments Inc. (NASDAQ:VECO), Vipshop Holdings Limited (NYSE:VIPS), and SolarWindow Technologies, Inc. (OTC:WNDW).

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.